MENU
CLOSE

Home

Company

Mission

Resources

Resources

Get the latest insights into women's health infectious disease trends, best practices and research on specimen integrity and operational efficiency from the team behind LabReady.

Filter by content
Filter by topic
LabReady Blog
Is Cold Chain Bleeding Your Lab Dry?
Cold Chain collection and transport is expensive and has become increasingly difficult in delivering an accurate diagnosis to the patient. 
LabReady Blog
The ABC’s of GBS
GBS affects about 1 in every 2,000 babies in the United States
Videos
LabReady, Set, Go: Accurately Diagnosing Infections Faster and From Home (Video)
An interview with Leonard Weisman, Co-founder, President, and CTO, Vax-Immune Diagnostics by Kayleen Brown, Executive Editor for MedTech Strategist Broadcasting Network.
Ask the Expert Feature
Ask the Expert - Group B Strep and the Importance of Pre-Term Testing and Diagnostics
Vax-Immune Diagnostics believes strongly in the significance of educating the public about Group B Strep and other bacterium that can cause significant medical issues.  This “Ask the Experts” on Group B Strep asks questions of highly qualified physicians (are they all neonatologists) who deal with GBS on a daily basis.  Their answers may answer your questions.
LabReady Blog
COVID-19 Testing Payments and Regulations: What Labs Need to Know
A recent article posted on Quadex, reveals new rules and regulations for the reporting and reimbursement of Covid-19 test processes
LabReady Blog
Signs and Symptoms of GBS in Newborn Babies
Studies show that 90 percent of babies who get early-onset GBS disease begin to show signs of sickness within the first 24 hours of life

Sorry, no results were found.

By navigating this website, you agree to our Cookie Policy
LabReady | Logo